Presenting Company Slots Filling Quickly for Elsevier Business Intelligence's 'Investment in Innovation (IN3) Medical Device 360 Summit-San Francisco' Conference
October 15-17, 2012; InterContinental Mark Hopkins San Francisco
(firmenpresse) - SAN FRANCISCO, CA -- (Marketwire) -- 08/28/12 -- , the medtech industry's leading provider of strategic partnership and investment conferences, announced today that nearly 80 percent of its presenting company timeslots for the strategic partnering and investment conference on , already have been filled. will bring together a diverse and insightful group of key medtech thought leaders and investors -- from Corporate Business Development, Venture Capital and Strategic Investment, Start-Up Entrepreneurs and Industry Pioneers -- to candidly discuss the critical issues affecting all players in the medical device space. The two-day event will take place in the hub of device investment and innovation in the Bay Area, at the historic on Nob Hill.
will feature presentations by more than 30 early development- to commercial-stage start-up device companies seeking funding and/or strategic partnership. Confirmed presenters to date include: , , , , , , , , , , , , , , and .
In addition to the timely opening presentation -- "The 2012 Elections: Impact on FDA, Healthcare Reform and the Future of Medical Technology Innovation" by , President and CEO, Medical Device Manufacturers Association (MDMA) -- Summit-San Francisco also will feature a Fireside Chat by , internationally recognized cardiovascular surgeon, inventor and entrepreneur. Additionally, a special evening presentation will be given by , President, : Insightful panel topics will include: "; "; and, " Investors confirmed to participate to date include ; ; ; ; ; ; ; ; and , among many others.
(timeslots on Oct. 16th are sold out). These interviews will be featured post-conference at . All of the one-on-one interviews with presenting-company CEOs will take place at, and during, the Summit-San Francisco conference and be organized by , President of Ronald Trahan Associates, Inc.
This two-day Summit-San Francisco conference will benefit anyone with a stake in the medical device sector: start-ups seeking investment or strategic partnership, investment firms, VCs, mid-size and large device manufacturers, and service providers. Partnering software will be available to all registered attendees prior to the conference so that one-on-one on-site meetings can be pre-arranged.
Event co-sponsors include , , , MassMedic Angels, and . Visit for full conference and registration details.
Elsevier Business Intelligence (EBI), an Elsevier company built on the heritage of F-D-C Reports, Windhover Information and Medtech Insight, is a global information supplier providing business intelligence on regulatory, business and reimbursement issues that are vital to the healthcare industry. Through a range of products including publications, conferences, and reports, EBI places biopharma and medical device professionals, and those who focus on these industries, at the forefront of knowledge, by providing the perfect combination of news and information together with penetrating insight and analysis. EBI () has offices in the U.S. in Bridgewater, N.J.; Norwalk, Conn.; Rockville, Md.; and Irvine, Calif.
Contact:
Ronald Trahan, APR
Ronald Trahan Associates Inc.
508-359-4005, x108
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 28.08.2012 - 13:00 Uhr
Sprache: Deutsch
News-ID 178168
Anzahl Zeichen: 0
contact information:
Town:
SAN FRANCISCO, CA
Kategorie:
Commercial & Investment Banking
Diese Pressemitteilung wurde bisher 171 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Presenting Company Slots Filling Quickly for Elsevier Business Intelligence's 'Investment in Innovation (IN3) Medical Device 360 Summit-San Francisco' Conference"
steht unter der journalistisch-redaktionellen Verantwortung von
Elsevier Business Intelligence (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
